HAGIWARA MASATOSHI has a total of 20 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are KINETA INC, AICURIS GMBH & CO KG and AICURIS GMBH AND CO KG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | China | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Canada | 2 | |
#6 | Japan | 2 | |
#7 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology | |
#5 | Computer technology |
# | Name | Total Patents |
---|---|---|
#1 | Hagiwara Masatoshi | 20 |
#2 | Hosoya Takamitsu | 12 |
#3 | Suzuki Masaaki | 12 |
#4 | Fukuhara Takeshi | 12 |
#5 | Nishida Atsushi | 5 |
#6 | Matsuo Masafumi | 5 |
#7 | Kataoka Naoyuki | 5 |
#8 | Ohki Shinichi | 1 |
#9 | Oki Shinichi | 1 |
#10 | Takeuchi Akihide | 1 |
Publication | Filing date | Title |
---|---|---|
US2013102644A1 | Prophylactic or ameliorating agent for genetic diseases | |
US2013137099A1 | Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in mammalian organisms | |
EP1712242A1 | Method of regulating phosphorylation of sr protein and antiviral agents comprising sr protein activity regulator as the active ingredient | |
JP2005229805A | Method for simulating life science and life science simulator |